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term anticoagulation therapy to prevent surface clotting.
Risks associated with anticoagulation therapy, such as
bleeding or thromboembolism, are of concern to many
patients. Although biologic tissue valves do not require
anticoagulation therapy, their durability is limited by
structural degeneration, calcification, or both.1
It is unclear whether the degeneration of porcine
valve prostheses is mediated by immune rejection.
Porcine hearts transplanted into human subjects prompt
a violent hyperacute rejection similar to that seen in
ABO-incompatible transplantation in which the graft
becomes cyanotic and edematous minutes after implan-
tation.2 The mechanism of porcine tissue rejection was
elucidated in 1987, when Galili and colleagues3 showed
that human subjects constitutively synthesize im-
munoglobulin (Ig) M natural antibodies against a
porcine endothelial molecule, galactose α-1,3-galactose
(α-Gal). The extensive microvascular thrombosis of
D iseased cardiac valves are replaced with eithermechanical or biologic tissue prostheses.
Mechanical valves are more durable but require long-
Objective: Transplanted porcine hearts are hyperacutely rejected by
human immunoglobulin M antibodies against a porcine vascular endothe-
lial molecule, galactose α-1,3-galactose, with ensuing human comple-
ment activation and membrane attack complex deposition. It is unclear,
however, whether porcine valve endothelium triggers a similar immune
response. We sought to investigate whether fresh porcine valves implant-
ed into primates are rejected.
Methods: Wild-type porcine hearts before (n = 6) and after (n = 3) hetero-
topic transplantation into baboons underwent sectioning and were examined
by hematoxylin and eosin staining and immunohistochemistry for galactose
α-1,3-galactose, primate immunoglobulin M, and membrane attack com-
plex.
Results: Examination of untransplanted porcine hearts showed that although
cardiac microvascular endothelium strongly expressed the galactose α-1,3-
galactose antigen, galactose α-1,3-galactose was not detected on the
endothelium of porcine aortic and pulmonary valves. Porcine hearts trans-
planted into baboon recipients were hyperacutely rejected 60 to 80 minutes
after implantation. Despite dramatic tissue damage associated with extensive
immunoglobulin M and membrane attack complex binding on the microvas-
cular endothelium, the aortic and pulmonary valves were entirely spared.
Valves remained morphologically intact at explant and showed no signs of
immunoglobulin M– and membrane attack complex–mediated damage.
Conclusions: The absence of galactose α-1,3-galactose expression may pro-
tect unfixed porcine valves from xenograft rejection in primates. Further
investigation of viable porcine valves appears warranted. (J Thorac
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hyperacute rejection is the result of IgM-triggered,
complement membrane attack complex (MAC)–medi-
ated graft destruction.
Because the mechanism of the human anti-pig
immune response is now understood, we sought to
determine whether human subjects mount a rejection
response against fresh porcine valves. We suspected
that valves may be immunologically distinct from heart
tissue. Previously, Mitchell and colleagues4 had shown
that cardiac valves, even in rejected human heart trans-
plants, rarely show any cellular infiltrate. Therefore, it
may be possible that valves, as nonvascularized tissue,
may be a low-visibility target for the immune system.
The potential immune privilege of valve tissue suggests
that porcine valve tissue may survive in human recipi-
ents. We thus sought to investigate the possibility of
implanting fresh porcine valves. Fresh porcine valves
contain viable endothelial and fibroblast cells, which
can continuously repair leaflets undergoing hemody-
namic stress and possibly confer better long-term dura-
bility.5
To examine the immune reaction against fresh
porcine valves, we performed heterotopic pig-to-
baboon cardiac xenotransplantation. Relative expres-
sion of α-Gal antigens on vascular and valve endothe-
lium was evaluated, and the degree of IgM and MAC
deposition on valve leaflets was compared with that on
cardiac microvasculature.
Material and methods
Experimental animals. Heterotopic pig-to-primate car-
diac xenotransplantation was performed to test the immune
reaction against fresh, unmanipulated, porcine valves.
Olive baboons (Papio anubis) served as transplant recipi-
ents, whereas wild-type (Parson Farm) pigs served as heart
donors. No immunosuppression was used for the study. All
animals received humane care in accordance with the
guidelines of the Harvard University Animal Care
Committee and the “Guide for the Care and Use of
Laboratory Animals” prepared by the Institute of
Laboratory Animal Resources and published by the
National Academy Press (National Academy Press publica-
tions No. xii-125, revised 1996).
Fig 1. Differential α-Gal expression on the endothelium of porcine valve leaflets versus microvasculature.
Untransplanted porcine hearts were examined for the expression of α-Gal. Porcine microvascular endothelium
show strong α-Gal expression (A). On the other hand, neither porcine aortic valves (B) nor pulmonary valves (C)
showed any detectable α-Gal expression.
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out immunosuppression. The hearts became edema-
tous, cyanotic, and engorged. Histologic examination
of the rejected graft showed signs of thrombi, intersti-
tial hemorrhage, and edema. There was extensive
microvascular IgM (Fig 2, A) and MAC (Fig 2, B)
deposition on the microvascular endothelium. Interest-
ingly, both aortic and pulmonary valves were intact,
and immunohistochemistry of pulmonary and aortic
valves showed no signs of either IgM (Fig 2, C) or
MAC (Fig 2, D).
Discussion
The use of animal valve prostheses was first pro-
posed and tested during the 1940s and 1950s. Although
the exact immune barriers of animal-to-human tissue
transplantation were not understood at that time, fail-
ures of organ transplantation convinced many that
valve transplantation would suffer the same fate.
Because of the difficult immunologic barriers of cross-
species transplantation, efforts were focused on prepar-
ing valves resistant to immune rejection. Fixatives were
introduced not as a method of decreasing antigenicity
but as a sterilizing and stiffening agent. In the first
experimental article describing the transplantation of
porcine valves, Duran and Gunning8 mentioned that
“the (porcine) graft was sterilized by immersion in liq-
uid ethylene oxide.” The other pioneers in the field,
Binet and colleagues,9 described “non-sterile pig and
calf aortic valves obtained immediately after death at
the slaughter house was at once placed in a mercurial
solution” for 3 days. Only after that were the valves
transferred into “sterile Gross’s solution.” The first
reported use of formaldehyde on valves was to dena-
ture and stiffen elastic fibers in human homografts.10
The first formaldehyde preservation of porcine valves
was performed by O’Brien,11 who used the solution in
1967 for “both preservation and sterilization.” Both
Hamilton and Gerbode12 and Paneth and O’Brien10
hypothesized that because formaldehyde “de-natures
the proteins of the graft, [it] may minimize rejection
phenomenon.” However, there was no experiment or
data to support this hypothesis.
A legacy of these early pioneers is glutaraldehyde-
fixed porcine valves, which have successfully served as
valve prostheses for the past 40 years. However, these
valves degenerate because of hemodynamic stress and
calcification. Fresh porcine valves may help to prevent
both problems. Fresh valves contain viable endothelial
and fibroblast cells, which may continue to repair and
modify the leaflets undergoing hemodynamic stress
and possibly confer better long-term durability.5
Historically, fresh valves have not been seriously con-
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Anesthesia. For invasive procedures and anesthesia induc-
tion, sedation was achieved by using ketamine hydrochloride
(10 mg/kg administered intramuscularly) in baboons and tilet-
amine hydrochloride and zolazepam hydrochloride (Telazol; 5
mg/kg administered intramuscularly) in pigs. Respiratory
secretions were controlled with atropine sulfate (0.03 mg/kg).
Anesthesia was maintained with inhalational isoflurane (1.3%-
2.0%). Intraoperatively, both pigs and baboons were monitored
with electrocardiography, noninvasive blood pressure monitor-
ing, and pulse oximetry. All baboons received antibiotic cover-
age with cefazolin (Ancef; 20 mg/kg administered intramuscu-
larly twice daily) and pain control with butrenorphine
(Buprenex; 0.005 mg/kg administered twice daily) postopera-
tively for 5 days. In the event of diminished fluid or caloric
intake, recipients received their calculated daily needs as intra-
venous crystalloid solution or Ensure tube feeds.
Heterotopic heart transplantation model.  Heart trans-
plantation was performed in the abdominal cavity, as previous-
ly described.6 Pigs were anesthetized and received systemic
anticoagulation with heparin (100 IU/kg administered intra-
venously), after which the heart was harvested in a standard
fashion after protection by 500 mL of antegrade cold crystal-
loid cardioplegic solution (dextrose, 2.5%; sodium chloride,
0.45%; potassium, 30 mEq/L; and bicarbonate, 5 mEq/L).
Transplant organ ischemic time varied between 45 and 55 min-
utes. The animals received no immunosuppression.
Histopathologic studies of the porcine valves. After graft
explantation, aortic and pulmonary valves were carefully dis-
sected and either snap-frozen in Tissue Freezing Medium
(Triangle Biomedical Sciences, Durham, NC) and liquid
nitrogen or fixed in Carnoy solution and embedded in paraf-
fin. Paraffin sections were sectioned at 5-µm thickness and
stained with hematoxylin and eosin. Biotinylated lectin from
Griffonia simplicifolia (Sigma, St Louis, Mo) was used to
stain α-Gal on porcine endothelium. Cryostat sections were
immunostained by use of standard indirect immunoperoxi-
dase avidin-biotin techniques, as previously summarized,7
with monoclonal antibodies specific for IgM (Biodesign
International, Kennebunk, Me) and MAC (C5-9; Dako,
Carpinteria, Calif). The signal was developed with the avidin-
peroxidase system (ABC kit; Vector Lab, Burlingame, Calif).
Results
Endothelium of porcine valves and cardiac
microvasculature. We examined untransplanted
porcine hearts (n = 6) to characterize α-Gal expres-
sion on the endothelium of valve leaflets and cardiac
microvasculature. Cardiac microvascular endotheli-
um showed strong α-Gal expression (Fig 1, A). In
comparison, neither aortic valves (Fig 1, B) nor pul-
monary valves (Fig 1, C) showed any detectable α-
Gal expression.
Porcine valves in hyperacute rejection.  Wild-type
porcine xenografts (n = 3) were hyperacutely rejected
60 to 80 minutes after implantation into baboons with-
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templated as possible valve prostheses, mainly because
of the assumption that all fresh porcine tissue, whether
myocardium or cardiac valves, would undergo rejec-
tion.
In this report, however, we found that porcine valvu-
lar leaflets do not express α-Gal on their endothelium.
The absence of detectable α-Gal on valvular leaflets
may have protected porcine valves from IgM-mediated
hyperacute rejection. Consequently, even though wild-
type porcine cardiac xenografts were destroyed within
60 to 80 minutes of implantation by severe IgM and
MAC deposition, aortic and pulmonary valves harvest-
ed from rejected xenografts showed no sign of damage.
The difference of α-Gal expression among different
endothelial layers was not totally unexpected because we
previously found that the endothelial cells of porcine car-
diac microvasculature express α-Gal, whereas those of
larger vessels do not.7 Decreased α-Gal expression on
valve endothelium could be due to either decreased gly-
cosylation or decreased surface glycoproteins on leaflet
endothelium. Protein expression is closely regulated in
endothelial cells, and flow rate can clearly modulate
endothelial gene expression. The expression of proteins,
such as major histocompatibility complex antigen13 and
vascular cell adhesion molecule 1,14 are all influenced by
the amount of shear force exerted on the endothelium.
Consequently, it is possible that shear force may also
modulate other genes, such as the gal α-1,3-galactosyl-
transferase gene. The gal α-1,3-galactosyltransferase
protein glycosylates the α-Gal terminal sugar to surface
proteins,15 and its expression is tightly controlled in the
porcine endothelium. For example, inflammatory
cytokines, such as tumor necrosis factor α and
lipopolysaccharide, decrease the level of gal α-1,3-
galactosyltransferase protein. Consequently, it is possi-
ble that differential shear forces exerted on cardiac
Fig 2. Porcine valves in hyperacute rejection. Wild-type pig hearts (n = 3) were transplanted into unmodified
baboon recipients. There was extensive microvascular IgM (A) and MAC (B) deposition on the cardiac microvas-
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valvular endothelium may influence gal α-1,3-galacto-
syltransferase gene expression and reduce Gal produc-
tion along the vascular system.
Alternatively, the differential Gal staining may be
reflective of the level of expression of glycoproteins on
porcine endothelium. Holzknecht and Platt16 showed
that the majority of porcine Gal epitopes bound by
human xenoreactive antibodies are found on the von
Willebrand factor and the integrin family α1, αv, α3/α5,β1, and β3. Ando and Kamiya17 also showed that β1
integrin is the signal-transducing mechanism for shear
stress within endothelial cells. Consequently, the popu-
lation of integrins may vary among endothelial cells
because of different stress, and the degree of Gal stain-
ing may vary accordingly.
Regardless of the exact mechanism for differential α-
Gal expression, the absence of α-Gal on porcine valvu-
lar endothelium protects the leaflets from xenoanti-
body-triggered rejection. To the best of our knowledge,
there has been no published report describing the
immunopathology of fresh porcine valves in human
subjects or primates. More studies in this area are war-
ranted to realize the potential of fresh porcine valve
prostheses.
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